XML 59 R39.htm IDEA: XBRL DOCUMENT v2.3.0.15
ASSET ACQUISITIONS AND DISPOSITION (Details) (USD $)
9 Months Ended
Sep. 30, 2011
Dec. 31, 2010
Sep. 30, 2011
Zovirax
Year
Mar. 31, 2011
Cloderm Cream
Sep. 30, 2011
Genzyme Corporation
Jun. 30, 2011
Genzyme Corporation
Feb. 09, 2011
Genzyme Corporation
Asset acquisitions and disposition       
(Acquisition) or disposition amount  $ (300,000,000)$ 36,000,000 $ (2,000,000)$ (2,000,000)
Term of distribution agreement (in years)  20    
Estimated weighted-average useful life (in years)  11    
Unamortized carrying value of product rights intangible asset6,359,974,0005,677,083,00091,400,00030,700,000   
Fair value of product rights intangible asset   31,800,000   
Additional milestone payment recieved    $ 5,000,000